Table 3 ARG identified in nasopharyngeal mNGS data.
ARG Product | ARG Class | No. of ARG in samples | Gene Coverage Range (> 25%) | ARG | ARG Class | No. of ARG in samples | Gene Coverage Range (> 25%) |
|---|---|---|---|---|---|---|---|
Aac3-Ik | Agly | 2 | 42–45 | MefA | MLS | 14 | 30–88 |
Aac6-Aph2 | Agly | 1 | 42 | MphC | MLS | 2 | 34–36 |
AadC | Agly | 3 | 34–81 | MphE | MLS | 4 | 26–100 |
Aph3-III | Agly | 3 | 26–43 | MsrA | MLS | 5 | 32–45 |
APH-Stph | Agly | 3 | 27–78 | MsrD | MLS | 23 | 29–100 |
Arr | RM | 4 | 28–98 | MsrE | MLS | 5 | 38–100 |
BlaZ | Bla | 5 | 34–98 | NorA | Flq | 2 | 30–90 |
BRO | Bla | 2 | 59–100 | OXA-23 | BL | 1 | 51 |
CatA2 | Phe | 4 | 99–100 | OXA-7 | BL | 3 | 30–93 |
CatA9 | Phe | 1 | 64 | PBP1a | BL | 2 | 36 |
CatB7 | Phe | 2 | 28–30 | PBP1b | BL | 7 | 28–96 |
CatQ | Phe | 2 | 42–52 | PenA | BL | 2 | 28–41 |
CfxA | Bla | 16 | 30–100 | PER-1 | BL | 2 | 54–99 |
Cmr | Phe | 2 | 30–99 | QnrB | Flq | 2 | 73–87 |
Dfr | Tmt | 3 | 30–34 | QnrVC1 | Flq | 4 | 39–97 |
DfrA1 | Tmt | 2 | 27–94 | Sat4A | Agly | 2 | 42–53 |
DfrA5 | Tmt | 3 | 41–89 | SPU | BL | 2 | 27–80 |
DfrC | Tmt | 6 | 27–86 | StrA | Agly | 2 | 59–76 |
Dha1 | Bla | 1 | 58 | StrB | Agly | 3 | 27–86 |
EBR-1 | Bla | 1 | 58 | SulI | Sul | 1 | 36 |
ErmA | MLS | 4 | 33–45 | TEM-1D | BL | 79 | 26–100 |
ErmB | MLS | 10 | 25–100 | Tet-32 | Tet | 5 | 26–100 |
ErmC | MLS | 4 | 29–100 | Tet-37 | Tet | 2 | 45–67 |
ErmF | MLS | 8 | 68–100 | Tet-38 | Tet | 1 | 77 |
ErmX | MLS | 7 | 27–100 | TetB | Tet | 1 | 100 |
Far1 | Bla | 2 | 30 | TetK | Tet | 3 | 36–100 |
FosA2 | FM | 1 | 90 | TetM | Tet | 18 | 26–100 |
FosB | FM | 1 | 90 | TetO | Tet | 1 | 100 |
LnuA | MLS | 1 | 31 | TetQ | Tet | 10 | 30–100 |
LnuC | MLS | 2 | 73–100 | TetW | Tet | 4 | 27–100 |
LsaC | MLS | 4 | 44–98 | TetZ | Tet | 1 | 58 |
MECA | Bla | 3 | 57–89 |
